Reduced platelet thromboxane formation after long - term administration of a dihydropyridine calcium channel blocker : a prospective , double - blind , placebo - controlled study with nitrendipine in <font color="blue">borderline_1</font> <font color="blue">hypertensive_1</font> <font color="blue">patients_1</font> <font color="blue">with_1</font> <font color="blue">IDDM_1</font> <font color="blue">-_1</font> <font color="blue">type_1</font> <font color="blue">diabetes_1</font> <font color="blue">mellitus_1</font> <font color="blue">._1</font> <font color="blue">
<br>
<br>_1</font> Twenty - nine IDDM patients with <font color="blue">borderline_1</font> <font color="blue">hypertension_1</font> were randomly allocated to placebo or nitrendipine treatment . Nitrendipine was given orally at a dosage of 20 mg once daily over 4 weeks . <font color="blue">Stimulated_1</font> <font color="blue">platelet_1</font> <font color="blue">thromboxane_1</font> <font color="blue">formation_1</font> <font color="blue">at_1</font> <font color="blue">rest_1</font> <font color="blue">and_1</font> <font color="blue">after_1</font> <font color="blue">standardized_1</font> <font color="blue">,_1</font> <font color="blue">non_1</font> <font color="blue">exhausting_1</font> <font color="blue">exercise_1</font> <font color="blue">was_1</font> <font color="blue">measured_1</font> <font color="blue">by_1</font> <font color="blue">standard_1</font> <font color="blue">methods_1</font> <font color="blue">._1</font> <font color="blue">In_1</font> <font color="blue">addition_1</font> <font color="blue">,_1</font> <font color="blue">plasma_1</font> <font color="blue">levels_1</font> <font color="blue">of_1</font> <font color="blue">platelet_1</font> <font color="blue">factor_1</font> <font color="blue">4_1</font> <font color="blue">and_1</font> <font color="blue">aggregation_1</font> <font color="blue">responses_1</font> <font color="blue">to_1</font> <font color="blue">collagen_1</font> <font color="blue">and_1</font> <font color="blue">ADP_1</font> <font color="blue">were_1</font> <font color="blue">determined_1</font> <font color="blue">._1</font> In the treatment group thromboxane formation after stimulation with collagen ( 0.3 and 1.0 micrograms / ml ) and 1 mM <font color="blue">arachidonic_1</font> <font color="blue">acid_1</font> <font color="blue">(_1</font> <font color="blue">AA_1</font> <font color="blue">)_1</font> was reduced in the resting state . <font color="blue">Exercise_3</font> <font color="blue">induced_3</font> <font color="blue">change_3</font> <font color="blue">of_3</font> <font color="blue">thromboxane_4</font> <font color="blue">synthesis_4</font> <font color="blue">in_1</font> <font color="blue">response_1</font> <font color="blue">to_1</font> <font color="blue">1.0_1</font> <font color="blue">micrograms_1</font> <font color="blue">/_1</font> <font color="blue">ml_1</font> <font color="blue">collagen_1</font> was significantly lower as compared to placebo ( p < 0.05 ) . In parallel , <font color="blue">PF4_3</font> <font color="blue">plasma_3</font> <font color="blue">levels_3</font> were significantly lowered ( p < 0.05 ) . <font color="blue">Whole_4</font> <font color="blue">blood_4</font> <font color="blue">aggregation_4</font> <font color="blue">after_2</font> <font color="blue">collagen_2</font> <font color="blue">stimulation_2</font> ( 1.0 micrograms / ml ) was reduced after 4 weeks of nitrendipine treatment , but <font color="blue">ADP_2</font> <font color="blue">(_2</font> <font color="blue">5_2</font> <font color="blue">microM_2</font> <font color="blue">)_2</font> <font color="blue">induced_2</font> <font color="blue">aggregation_2</font> was not . These <font color="blue">effects_1</font> of nitrendipine were not seen in platelet rich plasma . In conclusion long - term nitrendipine treatment may inhibit <font color="blue">collagen_2</font> <font color="blue">dependent_2</font> <font color="blue">platelet_2</font> <font color="blue">activation_2</font> in the blood of diabetic patients with borderline hypertension .